Hido Company Profile

Background

Company Overview

Hido is a digital health company specializing in AI-powered robotic solutions designed to enhance patient outcomes and reduce healthcare costs. Founded in 2019, Hido is headquartered in Sacramento, California, and operates with a team of approximately 16 employees across North America and Asia.

Mission and Vision

Hido's mission is to support patients, particularly those with chronic conditions, by ensuring medication adherence and enabling remote monitoring, thereby reducing hospitalizations and emergency room visits. The company's vision is to empower individuals to receive personalized care in the comfort of their homes, fostering independence and ensuring their well-being.

Industry Significance

Operating within the healthcare technology sector, Hido addresses critical challenges in patient care, such as medication non-adherence and the need for efficient home-based healthcare solutions. By leveraging artificial intelligence and robotics, Hido contributes to the transformation of healthcare delivery, emphasizing cost reduction and improved patient outcomes.

Key Strategic Focus

Core Objectives

Hido aims to revolutionize home-based healthcare by providing AI-driven solutions that ensure medication adherence, monitor patient behavior, and facilitate remote clinical interventions. The company focuses on reducing healthcare costs and hospitalizations through proactive, personalized care.

Areas of Specialization

Hido specializes in developing internet-connected robotic caregivers that continually capture digital biomarkers from monitored medication behaviors. These devices utilize facial recognition and video observation to ensure accurate medication intake and provide real-time data to healthcare providers and caregivers.

Key Technologies Utilized

Artificial Intelligence (AI): Employed for facial recognition and video analysis to monitor medication adherence.

Robotics: Integrated into home care devices to automate medication dispensing and patient monitoring.

Data Analytics: Utilized to process and interpret patient data, enabling remote monitoring and clinical interventions.

Primary Markets Targeted

Hido primarily targets healthcare providers, hospitals, Medicare Advantage plans, and insurance providers, aiming to improve patient engagement and reduce costs associated with medication non-adherence.

Financials and Funding

Funding History

Hido has secured funding from the National Institute on Aging (NIA) through a Phase II Small Business Innovation Research (SBIR) grant, titled "Preventing Medication Mismanagement in People Living with Dementia through Automated Medication Dispensing with Facial Recognition and Video Observation."

Total Funds Raised

Specific details regarding the total funds raised by Hido are not publicly disclosed.

Notable Investors

While individual investors are not specified, Hido's funding includes support from the National Institutes of Health (NIH), particularly the NIA.

Utilization of Capital

The capital is intended to further develop and test Hido's innovative technology aimed at addressing challenges in home-based healthcare for individuals with dementia.

Pipeline Development

Key Pipeline Candidates

Hido's primary product is an AI-powered robotic caregiver designed to automate medication dispensing and monitor patient behavior through facial recognition and video observation.

Stages of Development

The product is in the advanced stages of development, with ongoing testing and refinement supported by the Phase II SBIR grant from the NIA.

Target Conditions

The technology is specifically designed to assist individuals living with dementia, addressing challenges related to medication mismanagement and promoting independent living.

Anticipated Milestones

Hido aims to complete further development and testing phases, with plans to deploy the technology across the country, enhancing home-based care for individuals with chronic health conditions.

Technological Platform and Innovation

Proprietary Technologies

Automated Medication Dispensing: Ensures accurate and timely medication intake for patients.

Facial Recognition: Verifies patient identity to prevent medication errors.

Video Observation: Monitors patient behavior to assess medication adherence and overall well-being.

Significant Scientific Methods

AI and Machine Learning Algorithms: Analyze patient data to provide insights and support clinical decisions.

Remote Monitoring: Enables healthcare providers to oversee patient health metrics without in-person visits.

Leadership Team

Key Executives

Charles Gellman: Co-founder and CEO of HiDO Technologies, leading the company's strategic direction and innovation efforts.

Brandon Woolsey: Co-founder and CTO of HiDO Technologies, overseeing the technological development and implementation of the company's solutions.

Professional Backgrounds

Charles Gellman: Brings extensive experience in healthcare technology, focusing on developing solutions that enhance patient care and reduce costs.

Brandon Woolsey: Specializes in technology development, particularly in AI and robotics, with a focus on healthcare applications.

Key Contributions

Charles Gellman: Instrumental in securing funding and partnerships, including the Phase II SBIR grant from the NIA.

Brandon Woolsey: Led the development of the AI-powered robotic caregiver, integrating advanced technologies to monitor medication adherence.

Competitor Profile

Market Insights and Dynamics

The healthcare technology sector, particularly in home-based care solutions, is experiencing significant growth due to an aging population and the increasing prevalence of chronic conditions. Innovations in AI and robotics are driving advancements in patient care, offering opportunities for companies like Hido to lead in this evolving market.

Competitor Analysis

Hido operates in a competitive landscape with several key players:

Medtronic: Offers a range of healthcare solutions, including remote monitoring devices.

Philips Healthcare: Provides home healthcare technologies focusing on patient monitoring and diagnostics.

CarePredict: Develops AI-driven wearable devices for senior care, focusing on activity and health monitoring.

Strategic Collaborations and Partnerships

Hido's partnership with the National Institutes of Health (NIH), particularly the National Institute on Aging (NIA), has been pivotal in advancing its technology through the Phase II SBIR grant.

Operational Insights

Hido differentiates itself through its focus on AI-powered robotic solutions for home-based healthcare, addressing specific challenges in medication adherence and patient monitoring. The company's strategic collaborations enhance its capacity for innovation and market penetration.

Strategic Opportunities and Future Directions

Hido is well-positioned to expand its market presence by leveraging its technological innovations and strategic partnerships. Future opportunities include scaling operations to reach a broader patient base and exploring additional applications of its technology in chronic disease management.